Inactive Instrument

SCAPA GROUP

Equities

SCPA

GB0007281198

Scapa : Capital Markets Day

January 23, 2019 at 02:09 pm IST

23 January 2019

Scapa Group plc

Capital Markets Day

Manchester, United Kingdom - 23 January 2019 - Scapa Group plc (AIM: SCPA)will be holding a Capital Markets Day for analysts and investors today at the Company's newly acquired advanced wound care facility in Gargrave, UK. The event will include a presentation about the Company's strategy in healthcare as well as a tour of the state-of-the-art £31m acquisition which provides new opportunities for inception-to-delivery development and manufacturing services.

No new current trading information will be disclosed during the Capital Markets Day. Materials presented at the Capital Markets Day will be made available on the Group's website later today.

For more information, please contact:

Scapa Group plc Heejae Chae - Group Chief Executive Oskar Zahn - Chief Financial Officer	+44 (0) 161 301 7400
Numis Securities Mark Lander Richard Thomas (Nominated Advisor)	+44 (0) 20 7260 1000
Berenberg (Joint Broker) Chris Bowman Toby Flaux	+44 (0) 20 3207 7800
FTI Consulting Brett Pollard Victoria Foster Mitchell	+44 (0) 20 3727 1000

ENDS

Attachments

Original document
Permalink

Disclaimer

Scapa Group plc published this content on 23 January 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 23 January 2019 08:38:07 UTC

Latest news about SCAPA GROUP

Schweitzer Mauduit International : Finalizes Acquisition of Scapa Group	15/21/15	MT
Schweitzer-Mauduit International, Inc. completed the acquisition of Scapa Group plc from a group of sellers.	15/21/15	CI
Scapa : Court Approves Scapa Group Acquisition By Schweitzer-Mauduit International Unit	13/21/13	MT
Scapa : Schweitzer-Mauduit Unit Lifts Scapa Takeover Bid to $571 Million	08/21/08	MT
Schweitzer Mauduit International : Mauduit to Buy UK's Scapa Group in GBP402.9 Million Deal	27/21/27	MT
Scapa : Schweitzer-Mauduit Unit Agrees to Take Over Scapa for $553.7 Million	27/21/27	MT
Schweitzer-Mauduit International, Inc. entered into a Scheme of Arrangement to acquire Scapa Group plc from a group of sellers for approximately £410 million.	27/21/27	CI
Scapa : Earnings Flash (SCPA.L) SCAPA GROUP Reports H1 EPS GBX-0.2	17/20/17	MT
Scapa : Earnings Flash (SCPA.L) SCAPA GROUP Reports H1 Revenue GBP122M	17/20/17	MT
Scapa Group plc Provides Revenue Guidance for the Second Half of Year 2020	17/20/17	CI
Scapa Group plc Reports Earnings Results for the Half Year Ended September 30, 2020	17/20/17	CI
Scapa Group plc Announces Revenue Results for the Six Months Ended 30 September 2020	13/20/13	CI
Certain Ordinary Shares of Scapa Group plc are subject to a Lock-Up Agreement Ending on 12-SEP-2020.	12/20/12	CI
Scapa Group plc Announces Board Changes	07/20/07	CI
Scapa Group plc Announces David Blackwood, Non-Executive Director, Intends to Step Down by the End of the Calendar Year 2020	07/20/07	CI
Scapa Group plc Announces Board Changes	23/20/23	CI
Scapa Group plc Reports Earnings Results for the Full Year Ended March 31, 2020	23/20/23	CI
Scapa Group plc Reports Revenue Results for the Year Ended March 31, 2020; Provides Revenue Guidance for the First Quarter of Fiscal Year 2021	14/20/14	CI
Scapa Group plc Announces Organizational and Board Changes	04/20/04	CI
Scapa Group plc Intends to Suspend the Annual Dividend	27/20/27	CI
Scapa Group plc Announces the Retirement of Pierre Guyot as Non-Executive Director of the Company, Effective 29 February 2020	28/20/28	CI
Scapa Group plc Provides Earnings Guidance for the Year 2020	12/20/12	CI
Scapa Group plc Appoints Tim Miller as Non-Executive Director	20/20/20	CI
Scapa Group plc Reports Earnings Results for the Half Year Ended September 30, 2019	19/19/19	CI
Scapa Group plc Reports Revenue Results for the Six Months Ended 30 September 2019	09/19/09	CI

Chart SCAPA GROUP

Duration

Period

More charts

Company Profile

Scapa Group plc is a United Kingdom-based global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets. The Company has a global footprint, with production sites in Asia, Europe and the United States. The Company conducts the activities through two distinct and separate businesses: Healthcare and Industrial business units. The Company's subsidiary Scapa Healthcare is a outsource partner in the advanced wound care, consumer wellness, medical device fixation and drug delivery markets. Scapa Industrial operates across a diverse range of market segments throughout Europe, North America and Asia, through the two business models of engineered products and commercial products.

Sector

More about the company